Cargando…
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
BACKGROUND AND OBJECTIVES: The relationship between smoking, long-term brain atrophy, and clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long-term effects of smoking by evaluating MRI and clinical outcome measures after 10 years in smoking and nonsmoking p...
Autores principales: | Lie, Ingrid Anne, Wesnes, Kristin, Kvistad, Silje S., Brouwer, Iman, Wergeland, Stig, Holmøy, Trygve, Midgard, Rune, Bru, Alla, Edland, Astrid, Eikeland, Randi, Gosal, Sonia, Harbo, Hanne F., Kleveland, Grethe, Sørenes, Yvonne S., Øksendal, Nina, Barkhof, Frederik, Vrenken, Hugo, Myhr, Kjell-Morten, Bø, Lars, Torkildsen, Øivind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223432/ https://www.ncbi.nlm.nih.gov/pubmed/35738901 http://dx.doi.org/10.1212/NXI.0000000000200008 |
Ejemplares similares
-
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022) -
No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016) -
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020) -
Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)